ebiomedicine.bsky.social
Leading biomedical #openaccess journal, bridging the gap between basic and clinical research. Part of The Lancet Discovery Science. IF=10.8 🌐 https://www.thelancet.com/journals/ebiom/home
👤 Joined on 06 December 2024
Followers
Following
Total Posts
@ebiomedicine.bsky.social1/3: Can MS-based proteomics see what histology can’t? We profiled 83 rare paediatric adrenocortical tumours from archival FFPE tissue & found 4 proteome-defined states that predict survival better. Now in @ebiomedicine.bsky.social, led by Rainer Claus & Andreas Metousis. doi.org/10.1016/j.eb...
Show PostPublished in @ebiomedicine.bsky.social A proteome-based classification of paediatric #adrenocortical #tumours links functional tumour states to clinical outcome and therapeutic vulnerabilities www.thelancet.com/journals/ebi... #OpenAccess #MedSky #EndoSky
Show PostOur recent study now in @ebiomedicine.bsky.social investigates how pregnancy impacts the immune system. We identify key differences in circulating and decidual immune cell populations during pregnancy, with a focus on natural killer cells. Check out the details here: tinyurl.com/mvk8xcsx
Show PostCommon chemicals called #phthalates, which are used in plastics, cosmetics and personal care products, may affect several different cell types in the human ovary, including cells from the ovary’s nervous system. New study published in @ebiomedicine.bsky.social 🧪 #fertility news.ki.se/phthalates-a...
Show PostPublished in @ebiomedicine.bsky.social Metabolomic profiling of ultra-processed food consumption and #cardiovascular risk in Spanish preschool children: a cross-sectional study www.thelancet.com/journals/ebi... #UPFs #CVD #OpenAccess #MedSky #EndoSky #CardioSky
Show Post